The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome

(2012) Xiao Li et al.   Journal of Thoracic Oncology

Increased aldehyde dehydrogenase activity in high-risk chronic lymphocytic leukemia

(2012) Raymond P. Wu et al.   LEUKEMIA & LYMPHOMA

ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis

(2012) Jingwei Jiang et al.   MOLECULAR BIOLOGY REPORTS

Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma-their prognostic significance

(2012) Koji Okudela et al.   PATHOLOGY INTERNATIONAL

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

(2011) Prudence A. Russell et al.   Journal of Thoracic Oncology

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma

(2011) Dong Liang et al.   MEDICAL ONCOLOGY

Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling

(2010) J. P. Sullivan et al.   CANCER RESEARCH

Local recurrence after surgery for early stage lung cancer

(2009) Chris R. Kelsey et al.   CANCER

Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer

(2009) Rodrigo Arriagada et al.   JOURNAL OF CLINICAL ONCOLOGY

Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

(2009) F. Jiang et al.   MOLECULAR CANCER RESEARCH

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non–small cell lung cancer

(2008) Kentaroh Miyoshi et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY